LSV Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8
| Closed | -$5K | – | 857 |
|
|
2025
Q1 | $5K | Buy |
8
+4
| +100% | +$2.5K | ﹤0.01% | 829 |
|
|
2024
Q4 | $3K | Buy |
+4
| New | +$3K | ﹤0.01% | 823 |
|
|
2023
Q2 | – | Sell |
-49,400
| Closed | -$40.6M | – | 920 |
|
|
2023
Q1 | $40.6M | Sell |
49,400
-2,700
| -5% | -$2.22M | 0.09% | 226 |
|
|
2022
Q4 | $37.6M | Sell |
52,100
-1,700
| -3% | -$1.23M | 0.08% | 230 |
|
|
2022
Q3 | $37.1M | Sell |
53,800
-3,600
| -6% | -$2.48M | 0.09% | 231 |
|
|
2022
Q2 | $33.9M | Sell |
57,400
-134,330
| -70% | -$79.4M | 0.07% | 246 |
|
|
2022
Q1 | $134M | Sell |
191,730
-8,527
| -4% | -$5.96M | 0.25% | 128 |
|
|
2021
Q4 | $126M | Sell |
200,257
-9,610
| -5% | -$6.07M | 0.22% | 138 |
|
|
2021
Q3 | $127M | Sell |
209,867
-26,520
| -11% | -$16M | 0.23% | 130 |
|
|
2021
Q2 | $132M | Sell |
236,387
-15,564
| -6% | -$8.69M | 0.22% | 141 |
|
|
2021
Q1 | $119M | Sell |
251,951
-11,731
| -4% | -$5.55M | 0.2% | 150 |
|
|
2020
Q4 | $127M | Sell |
263,682
-34,930
| -12% | -$16.9M | 0.23% | 130 |
|
|
2020
Q3 | $167M | Sell |
298,612
-23,024
| -7% | -$12.9M | 0.34% | 92 |
|
|
2020
Q2 | $201M | Sell |
321,636
-63,502
| -16% | -$39.6M | 0.42% | 63 |
|
|
2020
Q1 | $188M | Buy |
385,138
+83,818
| +28% | +$40.9M | 0.45% | 53 |
|
|
2019
Q4 | $113M | Buy |
301,320
+275,290
| +1,058% | +$103M | 0.18% | 153 |
|
|
2019
Q3 | $7.22M | Buy |
+26,030
| New | +$7.22M | 0.01% | 500 |
|